Linkevicius, MariusBonnin, Rémy A.Alm, ErikSvartström, OlovApfalter, PetraHartl, RainerHasman, HenrikRoer, LouiseRäisänen, KatiDortet, LaurentPfennigwerth, NielsHans, Jörg B.Tóth, ÁkosBuzgó, LillaCormican, MartinDelappe, NiallMonaco, MonicaGiufrè, MariaHendrickx, Antoni P.A.Samuelsen, ØrjanPöntinen, Anna K.Caniça, ManuelaManageiro, VeraOteo-Iglesias, JesúsPérez-Vázquez, MaríaWestmo, KarinMäkitalo, BarbroPalm, DanielMonnet, Dominique L.Kohlenberg, Anke2024-01-252024-01-252023-05-11Euro Surveill. 2023 May;28(19):2300209. doi: 10.2807/1560-7917.ES.2023.28.19.2300209http://hdl.handle.net/10400.18/8978(This article belongs to the Special Issue Pharmacological Studies of Medicinal Potential Phytochemicals in Plant Roots)Whole genome sequencing data of 874 Escherichia coli isolates carrying bla NDM-5 from 13 European Union/European Economic Area countries between 2012 and June 2022 showed the predominance of sequence types ST167, ST405, ST410, ST361 and ST648, and an increasing frequency of detection. Nearly a third (30.6%) of these isolates were associated with infections and more than half (58.2%) were predicted to be multidrug-resistant. Further spread of E. coli carrying bla NDM-5 would leave limited treatment options for serious E. coli infections.engCarbapenem-resistant EnterobacteralesEscherichia coliNDM-5CarbapenemaseCross-border ImportSurveillanceWhole-genome SequencingResistência aos Antimicrobianosjournal article10.2807/1560-7917.ES.2023.28.19.2300209